InvestorsHub Logo
Followers 62
Posts 7548
Boards Moderated 1
Alias Born 01/02/2003

Re: JRoon71 post# 399025

Friday, 01/20/2023 4:41:01 PM

Friday, January 20, 2023 4:41:01 PM

Post# of 425892
The primary disadvantage with gV would be the oxidization of EPA in its inferior gelatin capsule...as compared with the oxidization of EPA in Vascepa....It would have made sense for Amarin to store gV on its shelves for x number of years and then to do tests to compare the oxidization of the EPA in gV compared to that of Vascepa.

The bad odor and bad taste of gV, alone, might not be enough for the FDA to take action.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News